Recent publications reported that PTOV1 cooperates with Zyxin in retinoic acid receptor (RAR) repression by abolishing the binding of the RAR coactivator CBP to the RAR target in non-small-cell lung cancer cells [16, 17]. The gene discussed is ZYX; the disease is non-small cell lung carcinoma.